57 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
1 Recruiting IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Condition: Keratosis, Actinic
Interventions: Drug: Imiquimod;   Drug: 5-fluorouracil;   Drug: Ingenol mebutate;   Procedure: methylaminolevulinate photodynamic therapy
2 Recruiting Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Conditions: Therapy, Photodynamic;   Keratosis, Actinic;   Pain
Interventions: Device: BF-RhodoLED;   Device: Aktilite CL128;   Drug: BF200-ALA/5-aminolevulinic acid
3 Recruiting Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Procedure: Aminolevulinic acid based photodynamic therapy
4 Recruiting A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Solution;   Other: Vehicle Solution
5 Recruiting A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Solution;   Other: Vehicle Solution
6 Recruiting Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 2.3% of SM
7 Not yet recruiting Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Procedure: Topical retinoid and blue-light therapy with photosensitizing agent;   Procedure: Photodynamic Therapy (PDT)
8 Recruiting Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Conditions: Actinic Keratosis;   Natural Daylight Photodynamic Therapy
Interventions: Drug: Aminolevulinic Acid;   Drug: Methyl 5-aminolevulinate
9 Unknown  Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
Condition: Actinic Keratoses
Interventions: Other: photodynamic therapy;   Drug: imiquimod 5% cream
10 Recruiting The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate
11 Unknown  Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
12 Recruiting Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Condition: Actinic Keratosis
Intervention: Drug: Inggenol Mebutate 0.015%
13 Unknown  Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm
14 Recruiting Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
Condition: Actinic Keratosis
Interventions: Drug: METHYLAMINOLEVULINATE HYDROCHLORIDE;   Drug: AMINOLEVULINIC ACID HYDROCHLORIDE
15 Recruiting Actinic Keratoses Treatment With Metvix® in Combination With Light
Condition: Actinic Keratoses
Interventions: Drug: Metvix®;   Procedure: Photodynamic Therapy Blue light;   Procedure: Photodynamic Therapy Daylight
16 Recruiting Biological Effects of LEO 43204 in Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: LEO 43204 Gel, 0.037%
17 Recruiting Metvix Daylight PDT in Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Other: Metvix
18 Not yet recruiting Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Conditions: Actinic Keratosis;   Non-melanoma Skin Cancer
Intervention: Drug: aminolevulinic acid HCl
19 Recruiting Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: SR-T100 Gel
20 Recruiting Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
Condition: Actinic Keratosis
Interventions: Drug: LEO43204 gel;   Drug: Vehicle gel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years